Research Directory

European biotech: Marching forward into 2025

Read more

Obesity Review, New drugs and new indications in the clinic, by Peter Charlish

Read more

GLP-1 agonists shake up the sector

Read more

The quest for non-addictive chronic pain therapies

Read more

Breakthroughs for European bipharma over the horizon

Read more

Pharma invests in R&D across a broad front

Read more

Swiss biotech attracted record financing in 2020

Read more

New treatments for amyotrophic lateral sclerosis

Read more

Market Analysis: The outlook for European pharma

Read more

A turning point for the biopharma industry?

Read more